Sayre Therapeutics Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 33

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $1M

  • Investors
  • 3

Sayre Therapeutics General Information

Description

Developer of a drug development platform designed to specialize in treating cancer and immunity-related diseases. The company's tool facilitates the development and registration of novel, drug-delivery devices, and companion diagnostics, enabling pharmaceutical companies to commercialize proprietary drugs and medicines for the treatment of cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Number 91, 3rd Floor, G.R. Square
  • Amarjyothi Nagar HBCS Layout, Inner Ring road, Domlur
  • Bangalore, Karnataka 560071
  • India
+91 080
Primary Industry
Pharmaceuticals
Vertical(s)
Corporate Office
  • Number 91, 3rd Floor, G.R. Square
  • Amarjyothi Nagar HBCS Layout, Inner Ring road, Domlur
  • Bangalore, Karnataka 560071
  • India
+91 080

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sayre Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 05-Sep-2017 $1M Completed Generating Revenue
2. Early Stage VC 04-Sep-2017 Completed Generating Revenue
1. Early Stage VC (Series A) 07-Apr-2015 $3.97M $3.97M Completed Generating Revenue
To view Sayre Therapeutics’s complete valuation and funding history, request access »

Sayre Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Preference
Ordinary
Preference 79,800 $0.156163 $48.41 $48.41 1x $48.41 34.7%
To view Sayre Therapeutics’s complete cap table history, request access »

Sayre Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a drug development platform designed to specialize in treating cancer and immunity-related diseases. The co
Pharmaceuticals
Bangalore, India
33 As of 2025

Hyderabad, India
 

Cambridge, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Sayre Therapeutics Competitors (12)

One of Sayre Therapeutics’s 12 competitors is Hetero, a Corporation company based in Hyderabad, India.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Hetero Corporation Hyderabad, India
Alyssum Therapeutics Venture Capital-Backed Cambridge, MA
Laborate Pharmaceuticals India Corporation Panipat, India
Auron Therapeutics Venture Capital-Backed Newton, MA
Intas Pharmaceuticals Private Equity-Backed Ahmedabad, India
You’re viewing 5 of 12 competitors. Get the full list »

Sayre Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sayre Therapeutics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
InnoVen Capital Lender/Debt Provider
Aarin Capital Partners Venture Capital Minority
Accel Partners Management (Palo Alto) Venture Capital Minority
To view Sayre Therapeutics’s complete investors history, request access »

Sayre Therapeutics FAQs

  • When was Sayre Therapeutics founded?

    Sayre Therapeutics was founded in 2015.

  • Where is Sayre Therapeutics headquartered?

    Sayre Therapeutics is headquartered in Bangalore, India.

  • What is the size of Sayre Therapeutics?

    Sayre Therapeutics has 33 total employees.

  • What industry is Sayre Therapeutics in?

    Sayre Therapeutics’s primary industry is Pharmaceuticals.

  • Is Sayre Therapeutics a private or public company?

    Sayre Therapeutics is a Private company.

  • What is Sayre Therapeutics’s current revenue?

    The current revenue for Sayre Therapeutics is .

  • How much funding has Sayre Therapeutics raised over time?

    Sayre Therapeutics has raised $9.2M.

  • Who are Sayre Therapeutics’s investors?

    InnoVen Capital, Aarin Capital Partners, and Accel Partners Management (Palo Alto) have invested in Sayre Therapeutics.

  • Who are Sayre Therapeutics’s competitors?

    Hetero, Alyssum Therapeutics, Laborate Pharmaceuticals India, Auron Therapeutics, and Intas Pharmaceuticals are some of the 12 competitors of Sayre Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »